Results 31 to 40 of about 155,199 (206)
Actas Dermo-SifiliográficasAnifrolumab is an inhibitor of the type I interferon receptor subunit 1 (IFNAR1) recently approved for the management of moderate-to-severe systemic lupus erythematosus (SLE).
D. Martín-Torregrosa +2 more
semanticscholar +1 more source
Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis
Frontiers in Immunology, 2020 Cutaneous Lupus Erythematosus (CLE) is a clinically diverse group of autoimmune skin diseases with shared histological features of interface dermatitis and autoantibodies deposited at the dermal–epidermal junction.
Colton J. Garelli +5 more
semanticscholar +1 more source
Subacute Cutaneous Lupus Erythematosus
Journal of Investigative Dermatology, 1993 Gilliam recognized subacute cutaneous lupus erythematosus (SCLE) as a lupus-specific eruption that identifies a unique subset of lupus erythematosus. These patients were noted to have prominent photoaggravated skin disease and often had musculoskeletal complaints, but generally did not develop significant systemic disease.
openaire +2 more sources
A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment
Indian Journal of Ophthalmology, 2013 Cutaneous lupus erythematosus is a previously undiagnosed side-effect of ranibizumab. Here, we present a case of an 82-year-old female Caucasian patient with wet age-related macular degeneration.
Marko Andric +4 more
doaj +1 more source
Indian Dermatology Online Journal, 2020 Discoid lupus erythematosus (DLE) is the most common variant of chronic cutaneous lupus erythematosus. Several cases of Blaschko-linear lupus erythematosus, which is regarded as a distinct subtype of lupus erythematosus, have been reported across the ...
Sanjiv Choudhary +3 more
doaj +1 more source
Cutaneous lupus erythematosus: pathogenesis, clinical pattern, diagnostics, therapy
Vestnik Dermatologii i Venerologii, 2017 This article contains the latest information about the mechanisms of development of lupus erythematosus based on the literature review. The modern classification of specific and non-specific skin lesions in lupus erythematosus is shown.The authors ...
P. N. Trofimov +5 more
doaj +1 more source
Anais Brasileiros de Dermatologia, 2011 Lúpus eritematoso cutâneo crônico é doença autoimune, com apresentações polimorfas que podem, eventualmente, mimetizar outras condições clínicas, causando dificuldade diagnóstica.
Daniela Ferro Farias +4 more
doaj +1 more source
Treatment of cutaneous lupus erythematosus: current approaches and future strategies.
Current Opinion in Rheumatology, 2020 PURPOSE OF REVIEW Cutaneous lupus erythematosus (CLE) is a highly heterogeneous autoimmune disease. No specific Federal Drug Administration (FDA)-approved therapies for CLE-alone are available, and resistance to conventional treatments is common.
Hong Shi, J. Gudjonsson, J. Kahlenberg
semanticscholar +1 more source
Chilblain lupus erythematosus in an adolescent girl
Indian Dermatology Online Journal, 2014 Chilblain Lupus Erythematosus (CHLE) is a rare form of cutaneous lupus erythematosus (LE), more frequently seen in middle aged females. It is characterized by erythematous to violaceous plaques over the acral areas induced by exposure to cold or drop in ...
Shikha Bansal, Alka Goel
doaj +1 more source
Frontiers in Immunology, 2023 IntroductionThe anti-programmed cell death protein 1 (PD-1) antibody cemiplimab has shown promising results in the treatment of unresectable or metastatic squamous cell carcinoma, however, frequently leads to immune-related adverse events limiting ...
Simon Fietz +8 more
doaj +1 more source